Is fluorescence in situ hybridization really superior to HercepTest?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 20 ·No. 23 ·2002-12-01 ·Pages 4607; author reply 4607-9

Birner P, Oberhuber G

Abstract

暂无摘要

MeSH Terms

Biomarkers, Tumor/analysis,genetics DNA, Neoplasm/analysis Gene Expression Regulation, Neoplastic Humans In Situ Hybridization, Fluorescence Predictive Value of Tests Receptor, ErbB-2/analysis,genetics United States United States Food and Drug Administration Up-Regulation

Chemicals

Biomarkers, Tumor DNA, Neoplasm Receptor, ErbB-2

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Birner Peter

Oberhuber Georg

Article Info

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abbr.

J Clin Oncol

ISSN

0732-183X

DOI

10.1200/JCO.2002.99.178

Published

2002-12-01

Pages

4607; author reply 4607-9

Language

English

Region

United States

NLM ID

8309333

Subset

Corrections

CommentOn

PMID: 12118023

External Links

PubMed source DOI: 10.1200/JCO.2002.99.178 View journal details

Analysis Services

Is fluorescence in situ hybridization really superior to HercepTest?

Contact

WeChat Official Account